Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence

Hyperphosphatemia is a common complication in dialysis-dependent patients with chronic kidney disease. Most dialysis-dependent patients need oral phosphate binder therapy to control serum phosphorus concentrations. Most phosphate binders have a high daily pill burden, which may reduce treatment adhe...

Descripción completa

Detalles Bibliográficos
Autores principales: Coyne, Daniel W., Sprague, Stuart M., Vervloet, Marc, Ramos, Rosa, Kalantar-Zadeh, Kamyar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995279/
https://www.ncbi.nlm.nih.gov/pubmed/35138627
http://dx.doi.org/10.1007/s40620-021-01241-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995279/
https://www.ncbi.nlm.nih.gov/pubmed/35138627
http://dx.doi.org/10.1007/s40620-021-01241-5

Ejemplares similares